Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Shuang-long Li, Yi Zhang, Qian-shi Cheng, Jun-zhe Xin, Ze-qin Dong & Xiang-jun Qiu. (2020) UPLC-MS/MS Measurement of the Effect of Isavuconazole, Itraconazole and Fluconazole on the Pharmacokinetics of Selinexor in Rats. Infection and Drug Resistance 13, pages 3153-3161.
Read now
Read now
Ivo Abraham, Luis Canais, Marti Larriva, Ali McBride, Reem Diri & Karen MacDonald. (2016) What does it take to provide cancer patients with comprehensive medication therapy management services for oral chemotherapy?. Expert Opinion on Drug Safety 15:4, pages 413-415.
Read now
Read now
Kevin Yi-Lwern Yap, Wai Keung Chui & Alexandre Chan. (2011) Development of a chemotherapy regimen interaction database for the mobile internet: detecting interactions with psychotropics through OncoRx-MI. Informatics for Health and Social Care 36:3, pages 132-146.
Read now
Read now
Articles from other publishers (37)
Belayneh Kefale, Melaku Tadege Engidaw, Desalegn Tesfa, Mulugeta Molla, Yitayih Kefale & Chernet Tafere. (2023) Management pattern and medication-related harms and its predictors in colorectal cancer patients: an institutional-based retrospective study. Frontiers in Oncology 13.
Crossref
Crossref
Belayneh Kefale, Melaku Tadege Engidaw, Desalegn Tesfa, Taklo Simeneh Yazie, Mulugeta Molla & Malede Berihun Yismaw. (2022) Clinical pattern and drug-related problems among colorectal cancer patients at oncology center in Ethiopia: A hospital-based study. SAGE Open Medicine 10, pages 205031212211316.
Crossref
Crossref
Efrat DotanLouise C. WalterIlene S. BrownerKatherine CliftonHarvey Jay CohenMartine ExtermannCary GrossSumati GuptaGenevieve HollisJoleen HubbardReshma JagsiNancy L. KeatingElizabeth KesslerThuy KollBeatriz Korc-GrodzickiJune M. McKoySumi MisraDominic MoonTracey O’ConnorCynthia OwusuAshley RoskoMarcia RussellMina SedrakFareeha SiddiquiAmy StellaDerek L. StirewaltIshwaria M. SubbiahWilliam P. TewGrant R. Williams, Liz HollingerGiby V. GeorgeHema Sundar. (2021) NCCN Guidelines® Insights: Older Adult Oncology, Version 1.2021. Journal of the National Comprehensive Cancer Network 19:9, pages 1006-1019.
Crossref
Crossref
Bushra Salman & Murtadha Al-Khabori. (2020) Applications and challenges in therapeutic drug monitoring of cancer treatment: A review. Journal of Oncology Pharmacy Practice 27:3, pages 693-701.
Crossref
Crossref
Kevin Yap, Eskinder Eshetu Ali & Lita Chew. 2021. Design and Quality Considerations for Developing Mobile Apps for Medication Management. Design and Quality Considerations for Developing Mobile Apps for Medication Management
1
31
.
Roger J. W. Hill, Pasquale F. Innominato, Francis Lévi & Annabelle Ballesta. (2020) Optimizing circadian drug infusion schedules towards personalized cancer chronotherapy. PLOS Computational Biology 16:1, pages e1007218.
Crossref
Crossref
Muge Akbulut & Yuksel Urun. (2020) Onco-cardiology: Drug-drug interactions of antineoplastic and cardiovascular drugs. Critical Reviews in Oncology/Hematology 145, pages 102822.
Crossref
Crossref
Lydia Sanchez, Astrid Bacle, Thierry Lamy & Pascal Le Corre. (2019) Potential drug–drug interactions and nephrotoxicity in hematopoietic stem cell transplant adult recipients during bone marrow transplantation unit stay. Cancer Chemotherapy and Pharmacology 83:5, pages 827-835.
Crossref
Crossref
R. Gironés Sarrió, M. Antonio Rebollo, M. J. Molina Garrido, C. Guillén-Ponce, R. Blanco, E. Gonzalez Flores & J. Saldaña. (2018) General recommendations paper on the management of older patients with cancer: the SEOM geriatric oncology task force’s position statement. Clinical and Translational Oncology 20:10, pages 1246-1251.
Crossref
Crossref
Saul N Weingart, Lulu Zhang, Megan Sweeney & Michael Hassett. (2018) Chemotherapy medication errors. The Lancet Oncology 19:4, pages e191-e199.
Crossref
Crossref
Arvind M. Shinde, Sumanta K. Pal & Arti Hurria. 2018. The American Cancer Society's Principles of Oncology. The American Cancer Society's Principles of Oncology
323
331
.
Ishwaria M. Subbiah, Jennifer J. Wheler, Kenneth R. Hess, David S. Hong, Aung Naing, Siqing Fu, Razelle Kurzrock & Apostolia M. Tsimberidou. (2017) Outcomes of patients ≥65 years old with advanced cancer treated on phase I trials at MD ANDERSON CANCER CENTER. International Journal of Cancer 140:1, pages 208-215.
Crossref
Crossref
Ma Ángeles Fernández de Palencia Espinosa, Ma Sacramento Díaz Carrasco, Andrés Sánchez Salinas, Amelia de la Rubia Nieto & Alberto Espuny Miró. (2016) Potential drug–drug interactions in hospitalised haematological patients. Journal of Oncology Pharmacy Practice, pages 107815521666420.
Crossref
Crossref
Silvia Ussai, Riccardo Petelin, Antonio Giordano, Mario Malinconico, Donatella Cirillo & Francesca Pentimalli. (2015) A pilot study on the impact of known drug-drug interactions in cancer patients. Journal of Experimental & Clinical Cancer Research 34:1.
Crossref
Crossref
Paula Stoll & Luciane Kopittke. (2015) Potential drug–drug interactions in hospitalized patients undergoing systemic chemotherapy: a prospective cohort study. International Journal of Clinical Pharmacy 37:3, pages 475-484.
Crossref
Crossref
Carmen Lopez-Martin, Margarita Garrido Siles, Julia Alcaide-Garcia & Vicente Faus Felipe. (2014) Role of clinical pharmacists to prevent drug interactions in cancer outpatients: a single-centre experience. International Journal of Clinical Pharmacy 36:6, pages 1251-1259.
Crossref
Crossref
M. Angeles Fernández de Palencia Espinosa, M. Sacramento Díaz Carrasco, José Luis Fuster Soler, Guadalupe Ruíz Merino, M. Amelia De la Rubia Nieto & Alberto Espuny Miró. (2014) Pharmacoepidemiological study of drug–drug interactions in onco-hematological pediatric patients. International Journal of Clinical Pharmacy 36:6, pages 1160-1169.
Crossref
Crossref
Schroder SattarShabbir M.H. AlibhaiHans Wildiers & Martine T.E. Puts. (2014) How to Implement a Geriatric Assessment in Your Clinical Practice. The Oncologist 19:10, pages 1056-1068.
Crossref
Crossref
Mihaela A. Popa, Kristie J. Wallace, Antonella Brunello, Martine Extermann & Lodovico Balducci. (2014) Potential drug interactions and chemotoxicity in older patients with cancer receiving chemotherapy. Journal of Geriatric Oncology 5:3, pages 307-314.
Crossref
Crossref
Saul N Weingart, Junya Zhu, Joanne Young-Hong, Holly Barr Vermilya & Michael Hassett. (2013) Do drug interaction alerts between a chemotherapy order-entry system and an electronic medical record affect clinician behavior?. Journal of Oncology Pharmacy Practice 20:3, pages 163-171.
Crossref
Crossref
Kevin Yi-Lwern Yap. 2013. User-Driven Healthcare. User-Driven Healthcare
1541
1588
.
A. Mouzon, J. Kerger, L. D'Hondt & A. Spinewine. (2013) Potential Interactions with Anticancer Agents: A Cross-Sectional Study. Chemotherapy 59:2, pages 85-92.
Crossref
Crossref
Kevin Yi-Lwern Yap. 2012. Pharmacoinformatics and Drug Discovery Technologies. Pharmacoinformatics and Drug Discovery Technologies
130
177
.
V. Girre, H. Arkoub, M.T.E. Puts, C. Vantelon, F. Blanchard, J.P. Droz & L. Mignot. (2011) Potential drug interactions in elderly cancer patients. Critical Reviews in Oncology/Hematology 78:3, pages 220-226.
Crossref
Crossref
K.Y.-L. YAP, W.L. TAY, W.K. CHUI & A. CHAN. (2011) Clinically relevant drug interactions between anticancer drugs and psychotropic agents. European Journal of Cancer Care 20:1, pages 6-32.
Crossref
Crossref
Ursula Theuretzbacher & Markus Zeitlinger. 2011. Principles and Practice of Cancer Infectious Diseases. Principles and Practice of Cancer Infectious Diseases
443
454
.
Martine T.E. Puts, Johanne Monette, Veronique Girre, Beatriz Costa-Lima, Christina Wolfson, Gerald Batist & Howard Bergman. (2010) Potential Medication Problems in Older Newly Diagnosed Cancer Patients in Canada during Cancer Treatment. Drugs & Aging 27:7, pages 559-572.
Crossref
Crossref
Mark N. Milton. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
218
.
Alain F. Pelfrène. 2010. Hayes' Handbook of Pesticide Toxicology. Hayes' Handbook of Pesticide Toxicology
2153
2217
.
Zhi-Yi Zhang, Mei Chen, Jennifer Chen, Mahesh V. Padval & Vikram V. Kansra. (2009) Biotransformation and in vitro assessment of metabolism-associated drug–drug interaction for CRx-102, a novel combination drug candidate. Journal of Pharmaceutical and Biomedical Analysis 50:2, pages 200-209.
Crossref
Crossref
Martine T.E. Puts, Beatriz Costa-Lima, Johanne Monette, Veronique Girre, Christina Wolfson, Gerald Batist & Howard Bergman. (2009) Medication Problems in Older, Newly Diagnosed Cancer Patients in Canada: How Common are They?. Drugs & Aging 26:6, pages 519-536.
Crossref
Crossref
Mark N. Milton. 2009. Drug Metabolism Handbook. Drug Metabolism Handbook
783
1000
.
Miriam B. Rodin. 2009. Geriatric Oncology. Geriatric Oncology
113
134
.
Chen-May Wong, Yu Ko & Alexandre Chan. (2008) Clinically Significant Drug–Drug Interactions Between Oral Anticancer Agents and Nonanticancer Agents: Profiling and Comparison of Two Drug Compendia. Annals of Pharmacotherapy 42:12, pages 1737-1748.
Crossref
Crossref
Russell E. Lewis. 2008.
Aspergillus fumigatus
and Aspergillosis
.
Aspergillus fumigatus
and Aspergillosis
445
456
.
Rachel P. Riechelmann. (2007) Drug combinations with the potential to interact among cancer patients. Supportive Care in Cancer 15:9, pages 1113-1114.
Crossref
Crossref
. (2007) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 16:6.
Crossref
Crossref